NCT00803855View on ClinicalTrials.gov

Study to Assess Safety, Tolerability and Pharmacokinetics After Single Doses of AZD1446 to Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

April 30, 2009

Study Completion Date

April 30, 2009

Conditions
Healthy
Interventions
DRUG

AZD1446

oral, single dose

Trial Locations (1)

Unknown

Research site, Huddinge

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY